Ever Fortune. AI (6841) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 長佳智能

Ever Fortune. AI (6841) reported revenue of NT$36.7 million for Oct 2026, -1.0% year on year and -0.7% from the previous month. Revenue for Jan–Oct 2026 was NT$310.9 million (+15.5% year on year).

In Oct 2026, it ranked No. 111 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$34.5 million24/10Nov 2024 NT$38.8 millionDec 2024 NT$33.1 millionJan 2025 NT$20.4 millionFeb 2025 NT$25.2 million25/02Mar 2025 NT$26.1 millionApr 2025 NT$28.1 millionMay 2025 NT$32.9 millionJun 2025 NT$26.3 million25/06Jul 2025 NT$29.1 millionAug 2025 NT$21.5 millionSep 2025 NT$22.4 millionOct 2025 NT$37.1 million25/10Nov 2025 NT$60.2 millionDec 2025 NT$45.1 millionJan 2026 NT$27.4 millionFeb 2026 NT$11.9 million26/02Mar 2026 NT$30.1 millionApr 2026 NT$33 millionMay 2026 NT$37.2 millionJun 2026 NT$27.9 million26/06Jul 2026 NT$29.9 millionAug 2026 NT$40 millionSep 2026 NT$37 millionOct 2026 NT$36.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$36.7 million-1.0%-0.7%
Sep 2026NT$37 million+65.3%-7.5%
Aug 2026NT$40 million+86.0%+33.9%
Jul 2026NT$29.9 million+2.5%+6.8%
Jun 2026NT$27.9 million+6.1%-24.8%
May 2026NT$37.2 million+12.9%+12.6%
Apr 2026NT$33 million+17.6%+9.8%
Mar 2026NT$30.1 million+15.0%+153.6%
Feb 2026NT$11.9 million-53.0%-56.8%
Jan 2026NT$27.4 million+34.6%-39.1%
Dec 2025NT$45.1 million+36.3%-25.1%
Nov 2025NT$60.2 million+55.2%+62.3%
Oct 2025NT$37.1 million+7.3%+65.8%
Sep 2025NT$22.4 million-31.5%+4.0%
Aug 2025NT$21.5 million-37.8%-26.3%
Jul 2025NT$29.1 million+4.7%+10.7%
Jun 2025NT$26.3 million-7.0%-20.1%
May 2025NT$32.9 million-12.7%+17.3%
Apr 2025NT$28.1 million+12.6%+7.4%
Mar 2025NT$26.1 million+23.7%+3.6%
Feb 2025NT$25.2 million+23.2%+23.8%
Jan 2025NT$20.4 million+81.0%-38.3%
Dec 2024NT$33.1 million+90.4%-14.7%
Nov 2024NT$38.8 million+146.8%+12.2%
Oct 2024NT$34.5 million+179.8%+5.9%

Jan–Oct 2026 cumulative: NT$310.9 million (+15.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Ever Fortune. AI vs PEC / Ever Fortune. AI vs Lotus Pharm / Ever Fortune. AI vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16